Skip to main content

Relias Media has upgraded our site!

Please bear with us as we work through some issues in order to provide you with a better experience.

Thank you for your patience.

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

Final CTU new 2019 masthead1

February 1, 2015

View Archives Issues

  • For Methods that are Reversible and Long-acting, the Upswing Continues

    Our annual contraception survey shows “dramatically more” women choosing intrauterine and implant contraception.

  • CTU remembers Michael Rosenberg, MD, MPH

    The reproductive health research community is paying tribute to Michael Rosenberg, MD, MPH, founder and chief executive officer of the Durham, NC-based clinical research organization, Health Decisions. Rosenberg was killed in a Dec. 8 plane crash in Maryland.

  • Ortho Evra patch discontinued — What next?

    Rewind to 2002: The first transdermal contraceptive, the Ortho Evra patch, hit U.S. pharmacy shelves. Fast forward to the present: The manufacturer has production of the device “due to a business decision,” according to information on the Food and Drug Administration (FDA) website.

  • With unsurpassed efficacy and rapid reversibility, contraceptive implant can be put into practice

    While use of long-acting reversible contraceptive (LARC) methods is growing, the contraceptive implant (Nexplanon, Merck & Co., Whitehouse Station, NJ) is still underused, say family planning experts. Look at the most recent national figures: In 2009, 8.5% of women using contraceptives relied on LARC methods, rising from 5.5% in 2007 and 2.4% in 2002. However, most of these women (nearly 8%) use intrauterine devices (IUDs), compared to less than 1% who use the implant.

  • Oral contraceptives — Should they be OTC?

    When it comes to moving oral contraceptives over the counter (OTC), almost 50% of participants in the Contraceptive Technology Update Contraception Survey say they support such a move. Support for OTC access is growing; 62% of American women support the pill being available without a prescription.

  • Despite new options, oral contraceptive pills are still in birth control mix, survey respondents say

    How are oral contraceptives being used in today’s family planning practices? The Affordable Care Act (ACA) might be making a difference when it comes to use of the Pill. Between 2012 and 2013, the number of women who filled prescriptions for the Pill with no co-pay more than quadrupled from 1.2 million to 5.1 million, according to data from the IMS Institute for Healthcare Informatics in Parsippany, NJ, an information and technology service.

  • Where should teens access condoms?

    On the most recent Youth Risk Behavior Survey (YRBS), 40% of sexually active U.S. high school students reported that they did not use a condom at last intercourse. This percentage has significantly declined since 1991 when the survey began but has increased since a low of 37% in 2003.1 Additionally, in 2013 less than 10% of students reported dual use of condoms plus a hormonal method.